Teva Pharmaceuticals (NDA Rights to Testosterone Gel 1%) is Buildings and Property in Israel that focus on testosterone gel business. They cover business area such as a testosterone gel, treatment, male hypogonadism, replacement therapy, condition, deficiency, absence, endogenous testosterone, primary hypogonadism, hypogonadotropic hypogonadism, their related disease.
-
Testosterone Gel
-
5 Basel St.
Petach Tikva 49131
Israel
Private
a testosterone geltreatmentmale hypogonadismreplacement therapyconditiondeficiencyabsenceendogenous testosteroneprimary hypogonadismhypogonadotropic hypogonadismtheir related disease
* We use standard office opening hours in near Teva Pharmaceuticals (NDA Rights to Testosterone Gel 1%)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Teva Pharmaceuticals (NDA Rights To Testosterone Gel 1%) is Buildings and Property business from Israel that founded in - ( years old in ), Teva Pharmaceuticals (NDA Rights to Testosterone Gel 1%) business is focusing on Testosterone Gel.
Teva Pharmaceuticals (NDA Rights to Testosterone Gel 1%) headquarter office and corporate office address is located in 5 Basel St. Petach Tikva 49131 Israel.
Teva Pharmaceuticals (NDA Rights to Testosterone Gel 1%) was founded in Israel.
In , Teva Pharmaceuticals (NDA Rights to Testosterone Gel 1%) is currently focus on testosterone gel sector.
Above is snippet of Google Trends for "testosterone gel" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Teva Pharmaceuticals (NDA Rights to Testosterone Gel 1%), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
